SGLT2 Inhibitors as Potential Anticancer Agents

Sodium-glucose cotransporter 2 (SGLT2) serves as a critical glucose transporter that has been reported to be overexpressed in cancer models, followed by increased glucose uptake in both mice and humans. Inhibition of its expression can robustly thwart tumor development in vitro and in vivo. SGLT2 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Basak, Debasish, Gamez, David, Deb, Subrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376602/
https://www.ncbi.nlm.nih.gov/pubmed/37509506
http://dx.doi.org/10.3390/biomedicines11071867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376602/
https://www.ncbi.nlm.nih.gov/pubmed/37509506
http://dx.doi.org/10.3390/biomedicines11071867

Ejemplares similares